MedTrace Logo

Effects of Enzymatic Digestion and Probiotic on Oleuropein Bioavailability

NCT04328571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-10-01

No results posted yet for this study

Summary

This is a 3-arms randomized-controlled, parallel group, single center, double-blind study investigating the bioavailability of olive oil extract (OLE) in two different OLE formulations (enzymatically treated and co-administered with a probiotic) compared to original OLE formulation in healthy adult subjects.

Conditions

  • Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

OLE enzymatically treated

OLE (Olive leaf extract ) enzymatically treated + maltodextrin

DIETARY_SUPPLEMENT

OLE + probiotic

OLE (Olive leaf extract) co-administered with probiotic

DIETARY_SUPPLEMENT

OLE

OLE (Olive leaf extract) + maltodextrin

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Francisco A. Tomás-Barberán, Prof. · CEBAS-CSIC, Murcia, Spain

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2021-05-15
Completion
2021-09-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328571 on ClinicalTrials.gov